Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/A
Aim. To evaluate long-term results of using xenogenic pericardial stentless prosthesis BioLAB KB/A.Material and methods. From 2007 to 2014, 57 xenogenic pericardial stentless prostheses BioLAB KB/A were implanted. The mean age of operated patients was 70±4 (49-80 years of age); 6 patients were young...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2020-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3966 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850031046223986688 |
|---|---|
| author | S. I. Babenko R. M. Muratov N. N. Soboleva D. A. Titov N. P. Bakuleva M. I. Fedoseikina |
| author_facet | S. I. Babenko R. M. Muratov N. N. Soboleva D. A. Titov N. P. Bakuleva M. I. Fedoseikina |
| author_sort | S. I. Babenko |
| collection | DOAJ |
| description | Aim. To evaluate long-term results of using xenogenic pericardial stentless prosthesis BioLAB KB/A.Material and methods. From 2007 to 2014, 57 xenogenic pericardial stentless prostheses BioLAB KB/A were implanted. The mean age of operated patients was 70±4 (49-80 years of age); 6 patients were younger than 65 years old. The mean follow-up period was 8 years (4-11 years). The mean age of patients at the time of examination was 79 (70-89) years.Results. Five- and ten-year survival rates were 73,82±7,99% and 51,01±11,23%, respectively. Four patients underwent long-term reoperation due to bioprosthetic valve dysfunction. Freedom from reoperation associated with infective endocarditis after a year was 95,1±2,4%, three years — 92,65±4,1%, five years — 89,1±5,2%, and seven years — 89,1±5,2%. Freedom from prosthetic valve dysfunction due to structural degeneration was 9,58±1,83 years.Conclusion. We consider it possible to use the xenogenic pericardial stentless prostheses BioLAB KB/A for aortic valve replacement in elderly patients, especially with a narrow aortic root. However, using a technically more complex technique for a larger geometric opening is not justified. Significant regurgitation at 7 years after surgery requires considering reoperation, but already in older patients and with a number of comorbidities. |
| format | Article |
| id | doaj-art-05067561731e420fa366bcf61fb2d1d9 |
| institution | DOAJ |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2020-12-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-05067561731e420fa366bcf61fb2d1d92025-08-20T02:59:04Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202020-12-01251210.15829/1560-4071-2020-39663102Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/AS. I. Babenko0R. M. Muratov1N. N. Soboleva2D. A. Titov3N. P. Bakuleva4M. I. Fedoseikina5Bakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryAim. To evaluate long-term results of using xenogenic pericardial stentless prosthesis BioLAB KB/A.Material and methods. From 2007 to 2014, 57 xenogenic pericardial stentless prostheses BioLAB KB/A were implanted. The mean age of operated patients was 70±4 (49-80 years of age); 6 patients were younger than 65 years old. The mean follow-up period was 8 years (4-11 years). The mean age of patients at the time of examination was 79 (70-89) years.Results. Five- and ten-year survival rates were 73,82±7,99% and 51,01±11,23%, respectively. Four patients underwent long-term reoperation due to bioprosthetic valve dysfunction. Freedom from reoperation associated with infective endocarditis after a year was 95,1±2,4%, three years — 92,65±4,1%, five years — 89,1±5,2%, and seven years — 89,1±5,2%. Freedom from prosthetic valve dysfunction due to structural degeneration was 9,58±1,83 years.Conclusion. We consider it possible to use the xenogenic pericardial stentless prostheses BioLAB KB/A for aortic valve replacement in elderly patients, especially with a narrow aortic root. However, using a technically more complex technique for a larger geometric opening is not justified. Significant regurgitation at 7 years after surgery requires considering reoperation, but already in older patients and with a number of comorbidities.https://russjcardiol.elpub.ru/jour/article/view/3966xenogenic pericardial stentless prosthesesbioprostheticsaortic valve |
| spellingShingle | S. I. Babenko R. M. Muratov N. N. Soboleva D. A. Titov N. P. Bakuleva M. I. Fedoseikina Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/A Российский кардиологический журнал xenogenic pericardial stentless prostheses bioprosthetics aortic valve |
| title | Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/A |
| title_full | Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/A |
| title_fullStr | Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/A |
| title_full_unstemmed | Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/A |
| title_short | Long-term results of aortic valve replacement with xenogenic pericardial stentless prosthesis BioLAB KB/A |
| title_sort | long term results of aortic valve replacement with xenogenic pericardial stentless prosthesis biolab kb a |
| topic | xenogenic pericardial stentless prostheses bioprosthetics aortic valve |
| url | https://russjcardiol.elpub.ru/jour/article/view/3966 |
| work_keys_str_mv | AT sibabenko longtermresultsofaorticvalvereplacementwithxenogenicpericardialstentlessprosthesisbiolabkba AT rmmuratov longtermresultsofaorticvalvereplacementwithxenogenicpericardialstentlessprosthesisbiolabkba AT nnsoboleva longtermresultsofaorticvalvereplacementwithxenogenicpericardialstentlessprosthesisbiolabkba AT datitov longtermresultsofaorticvalvereplacementwithxenogenicpericardialstentlessprosthesisbiolabkba AT npbakuleva longtermresultsofaorticvalvereplacementwithxenogenicpericardialstentlessprosthesisbiolabkba AT mifedoseikina longtermresultsofaorticvalvereplacementwithxenogenicpericardialstentlessprosthesisbiolabkba |